Fresh analysis indicates that patients who stop using new slimming jabs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop traditional diet and exercise plans.
Research printed in a leading health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Users buying such drugs need to be aware of the risk of quick rebound weight gain when the therapy ends," cautioned researcher Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment mass in about a year and a half.
Analyzing Treatments
The study, which examined 37 of trials involving thousands of patients, contrasted the results of these new drugs with older methods.
Scientists note that individuals who shed pounds through diet and exercise typically see a more gradual creep back—approximately 100 grams monthly—once they finish.
Understanding the Fast Rebound
Nutrition scientists suggest the way of the drugs accounts for the accelerated rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, considering the likelihood of relapse, the treatment is often long-term.
This perspective is echoed by drug manufacturers, who note that the findings "emphasize the chronic nature of obesity," akin to managing diseases like diabetes.
Patient Accounts
People who have come off the medication explain a powerful resurgence of hunger.
"It felt as if something activating and you're instantly ravenous," recalled a patient.
This difficulty is compounded if users have not adopted permanent lifestyle or habit changes during therapy.
Significant Adoption
Recent estimates suggest that a significant number of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is higher among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a magic solution and maintained weight loss relies on combined lifestyle changes.
